Yale University

Clinical case conference: unobserved "home" induction onto buprenorphine.

TitleClinical case conference: unobserved "home" induction onto buprenorphine.
Publication TypeJournal Article
Year of Publication2014
AuthorsLee, Joshua D., Jennifer McNeely, Ellie Grossman, Frank Vocci, and David A. Fiellin
JournalJournal of addiction medicine
Date Published2014 Sep-Oct
AbstractUnobserved or "home" buprenorphine induction has become a common clinical practice. Patients take the initial and subsequent doses of buprenorphine after, rather than during, an office visit. This clinical case summarizes an unobserved induction onto buprenorphine in a typical new patient. We review the core issues surrounding patient selection, feasibility, logistics, safety, and effectiveness of unobserved buprenorphine induction. Prescribers, treatment providers, policy makers, and patients should weigh the benefits of observed induction (maximum clinical supervision) with the reduced resource burden, flexibility, and comparable safety of unobserved induction.
Alternate JournalJ Addict Med

External Links